EUVIMEDEUVIMED entdecken
Crossref

Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity

Fawaz Mayez Mahfouz, Tiffany Li, Hannah C Timmins, Lisa G Horvath, Michelle Harrison, Peter Grimison, Gavin Marx, David Goldstein, Susanna B Park

Journal of the National Comprehensive Cancer Network · 2024

DOI: 10.6004/jnccn.2023.7083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024. Verfasst von Fawaz Mayez Mahfouz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Mind Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemotherapy-induced peripheral neurotoxicity (CIPN) affects the quality of life of cancer survivors. However, the impact of pain on symptom burden remains undefined. This study aimed to define differences in the clinical symptom profile of patients with painful and nonpainful CIPN. Patients and Methods: A total of 579 participants (median age, 59 years [IQR, 19 years]; F=66%) were assessed cross-sectionally 6 months posttreatment. CIPN severity was graded using multiple methods, including patient-reported outcome measures, a clinically graded scale (NCI-CTCAE), and a neurologic examination score. Participants were classified into subgroups based on patient symptom report, with painful CIPN characterized by the presence of shooting/burning pain, and nonpainful CIPN characterized by the presence of numbness or tingling without shooting/burning pain. Behavioral changes were assessed via structured patient interview regarding symptom impact on sleep, exercise, and treatment-seeking.

Results

Among 579 participants, 24% (n=140) reported painful CIPN, 48% (n=280) reported nonpainful CIPN, and 28% (n=159) had no CIPN. Participants with painful CIPN demonstrated higher CIPN severity than those with nonpainful CIPN across multiple measures, including NCI-CTCAE, neurologic grading, and patient report (all P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Nervous System DiseasesAntineoplastic AgentsNeoplasmsHumansMiddle AgedSymptom BurdenQuality of LifePain

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Brain and Mind Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
  • Chris O'Brien Lifehouse, Camperdown, Australia.
  • Sydney Medical School, The University of Sydney, Camperdown, Australia.
  • Royal Prince Alfred Hospital, Camperdown, Australia.
  • Sydney Adventist Hospital, Wahroonga, Australia.
  • Prince of Wales Clinical School, Faculty of Medicine & Health, UNSW Sydney, Randwick, Australia.

Zitieren

APA

Mahfouz, F. M., Li, T., Timmins, H. C., Horvath, L. G., Harrison, M., Grimison, P., Marx, G., Goldstein, D., & Park, S. B. (2024). Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2023.7083

Vancouver

Mahfouz FM, Li T, Timmins HC, Horvath LG, Harrison M, Grimison P, et al. Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity. Journal of the National Comprehensive Cancer Network. 2024. doi:10.6004/jnccn.2023.7083

BibTeX
@article{Mahfouz2024,
  author = {Mahfouz, Fawaz Mayez and Li, Tiffany and Timmins, Hannah C and Horvath, Lisa G and Harrison, Michelle and Grimison, Peter and Marx, Gavin and Goldstein, David and Park, Susanna B},
  title = {Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2024},
  doi = {10.6004/jnccn.2023.7083}
}
Kostenlos starten →